Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy.
BACKGROUND
The definition of what constitutes a normal TSH during pregnancy is in flux. Recent studies suggested that the first trimester upper limit of normal for TSH should be 2.5 mIU/liter.


OBJECTIVE
The objective of the study was to evaluate the pregnancy loss and preterm delivery rate in first-trimester thyroid peroxidase antibody-negative women with TSH values between 2.5 and 5.0 mIU/liter.


METHODS
The present study is a component of a recently published large-scale prospective trial that evaluated the impact of levothyroxine treatment on maternal and neonatal complications in thyroid peroxidase-positive women with TSH levels above 2.5 mIU/liter. The present study evaluated 4123 thyroid peroxidase antibody-negative women with TSH levels at or below 5.0 mIU/liter. Women were divided into two groups based on their initial TSH: group A, TSH level below 2.5 mIU/liter, excluding hyperthyroid women defined as an undetectable TSH with an elevated free T(4), and group B, TSH level between 2.5 and 5.0 mIU/liter.


METHODS
The study was conducted at two ambulatory clinics of community hospitals in southern Italy.


METHODS
A total of 4123 women were evaluated.


METHODS
There was no intervention.


METHODS
The incidence of pregnancy loss and preterm delivery in group A as compared with group B was measured.


RESULTS
The rate of pregnancy loss was significantly higher in group B as compared with group A (6.1 vs. 3.6% respectively, P = 0.006). There was no difference in the rate of preterm delivery between the two groups.


CONCLUSIONS
The increased incidence of pregnancy loss in pregnant women with TSH levels between 2.5 and 5.0 mIU/liter provides strong physiological evidence to support redefining the TSH upper limit of normal in the first trimester to 2.5 mIU/liter.
Division of Endocrinology, V. Fazzi Hospital, 73100 Lecce, Italy. dr.negro@libero.it.
Roberto
R
Negro
Alan
A
Schwartz
Riccardo
R
Gismondi
Andrea
A
Tinelli
Tiziana
T
Mangieri
Alex
A
Stagnaro-Green
D000022:Abortion, Spontaneous / Q000097:blood / Q000453:epidemiology / Q000209:etiology / Q000276:immunology; D000328:Adult; D016022:Case-Control Studies; D020964:Embryo Loss / Q000097:blood / Q000453:epidemiology* / Q000209:etiology / Q000276:immunology; D005260:Female; D006801:Humans; D018828:Immunoglobulins, Thyroid-Stimulating / Q000097:blood*; D015994:Incidence; D009994:Osmolar Concentration; D010298:Parity / Q000502:physiology; D011247:Pregnancy; D011261:Pregnancy Trimester, First / Q000097:blood* / Q000276:immunology; D012016:Reference Values; D013972:Thyrotropin / Q000032:analysis / Q000097:blood*; D055815:Young Adult
D018828:Immunoglobulins, Thyroid-Stimulating; D013972:Thyrotropin